Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC

CANTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Organogenesis, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly® AM, Affinity®, Apligraf®, NuShield®, Novachor™ and Organogenesis Physician Solutions product lines will be showcased at the 2022 Symposium on Advanced Wound Care (SAWC) Spring Conference held April 6-10, 2022 in Phoenix, Arizona.

“As a leading sponsor of this year’s conference, we are excited to share new research on our innovative product portfolio and hear from other thought leaders about advances in wound care,” said Katie Mowry, Assistant Vice President, Research and Development for Organogenesis … read more